These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24018451)

  • 1. [Fullerenol - properties and applications in biomedical sciences].
    Grębowski J; Kaźmierska P; Krokosz A
    Postepy Hig Med Dosw (Online); 2013 Aug; 67():859-72. PubMed ID: 24018451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fullerenols in therapy and diagnosis of cancer].
    Lichota A; Krokosz A
    Med Pr; 2016 Dec; 67(6):817-831. PubMed ID: 28005089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Fullerenols on Mouse Brain Microvascular Endothelial Cells.
    Schuhmann MK; Fluri F
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28817067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant Activity and Toxicity of Fullerenols via Bioluminescence Signaling: Role of Oxygen Substituents.
    Kovel ES; Sachkova AS; Vnukova NG; Churilov GN; Knyazeva EM; Kudryasheva NS
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fullerenols as a new therapeutic approach in nanomedicine.
    Grebowski J; Kazmierska P; Krokosz A
    Biomed Res Int; 2013; 2013():751913. PubMed ID: 24222914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyhydroxylated C(60), fullerenols, as glutamate receptor antagonists and neuroprotective agents.
    Jin H; Chen WQ; Tang XW; Chiang LY; Yang CY; Schloss JV; Wu JY
    J Neurosci Res; 2000 Nov; 62(4):600-7. PubMed ID: 11070504
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sharoyko VV; Iamalova NR; Ageev SV; Meshcheriakov AA; Iurev GO; Petrov AV; Nerukh DA; Farafonov VS; Vasina LV; Penkova AV; Semenov KN
    J Phys Chem B; 2021 Aug; 125(32):9197-9212. PubMed ID: 34375109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fullerenol C
    Grebowski J; Kazmierska P; Litwinienko G; Lankoff A; Wolszczak M; Krokosz A
    Biochim Biophys Acta Biomembr; 2018 Aug; 1860(8):1528-1536. PubMed ID: 29778781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and biocompatible characteristics of fullerenols nanomaterials for tissue engineering.
    Zhao Y; Shen X; Ma R; Hou Y; Qian Y; Fan C
    Histol Histopathol; 2021 Jul; 36(7):725-731. PubMed ID: 33604882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats.
    Trajković S; Dobrić S; Jaćević V; Dragojević-Simić V; Milovanović Z; Dordević A
    Colloids Surf B Biointerfaces; 2007 Jul; 58(1):39-43. PubMed ID: 17317115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Medical Use of Fullerenols After Two Decades of Oncology Research.
    Injac R
    Technol Cancer Res Treat; 2023; 22():15330338231201515. PubMed ID: 37724005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel C
    Nurzynska A; Piotrowski P; Klimek K; Król J; Kaim A; Ginalska G
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of the size and hydroxyl number of fullerenes/fullerenols on their interactions with proteins.
    Wu X; Yang ST; Wang H; Wang L; Hu W; Cao A; Liu Y
    J Nanosci Nanotechnol; 2010 Oct; 10(10):6298-304. PubMed ID: 21137722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fullerenols Mitigate Radiation-Induced Myocardial Injury.
    Zhang T; He R; Ding X; Zhao M; Wang C; Zhu S; Liao Y; Wang D; Wang H; Guo J; Liu Y; Zhou Z; Gu Z; Hu H
    Adv Healthc Mater; 2023 Nov; 12(29):e2300819. PubMed ID: 37698231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fullerenol-cytotoxic conjugates for cancer chemotherapy.
    Chaudhuri P; Paraskar A; Soni S; Mashelkar RA; Sengupta S
    ACS Nano; 2009 Sep; 3(9):2505-14. PubMed ID: 19681636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fullerenes in radiobiology].
    Grebowski J; Krokosz A
    Postepy Biochem; 2010; 56(4):456-62. PubMed ID: 21473050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small size fullerenol nanoparticles inhibit thrombosis and blood coagulation through inhibiting activities of thrombin and FXa.
    Xia S; Li J; Zu M; Li J; Liu J; Bai X; Chang Y; Chen K; Gu W; Zeng L; Zhao L; Xing G; Xing G
    Nanomedicine; 2018 Apr; 14(3):929-939. PubMed ID: 29309909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible [60]/[70] Fullerenols: Potent Defense against Oxidative Injury Induced by Reduplicative Chemotherapy.
    Zhou Y; Li J; Ma H; Zhen M; Guo J; Wang L; Jiang L; Shu C; Wang C
    ACS Appl Mater Interfaces; 2017 Oct; 9(41):35539-35547. PubMed ID: 28945341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versatile applications of fullerenol nanoparticles.
    Seke M; Zivkovic M; Stankovic A
    Int J Pharm; 2024 Jul; 660():124313. PubMed ID: 38857663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The properties of small fullerenol cluster (C60(OH)24)7: computer simulation.
    Piątek A; Dawid A; Gburski Z
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Aug; 79(4):819-23. PubMed ID: 20864388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.